The pharmaceutical industry and pharmacies are developed in a complex and highly regulated environment. Research of new drugs is quite expensive and you need enough time for it.
For that reason, pharmaceutical marketing professionals must be prepared to meet the challenges they encounter on the way to the success of the brands they manage.
This Master MBA with specialization in Pharmaceutical Marketing offers the opportunity to train and develop the skills in the field of business management, marketing, branding and digital communication in order to implement strategic plans to products, services or companies with the best strategy adapted to all current regulations.
This master aimed at the pharmaceutical industry claims that the student is able to implement a strategy to address successfully as well as enable you so you can evaluate the suitability of a business strategy, analyzing the marketing plan in which it is based, thus ensuring the desired results for your company.
MFI offers a flexible methodology adapted to your needs, whatever your geographical location or time availability. This master can be studied under:
All contents are fully updated and have great technical, easily understandable and with a clear practical vocation rigor. IMF offers you:
Continuous assessment as advances in the study of the Master. Each module will be assessed by combining online and development of case examination; overcoming will free each subject.
Likewise, obtaining master's degrees and Master MFI University Camilo José Cela, subject to overcoming each module testing and the development of a master work order.
Students who pass this master can work in:
This MSc will provide students with the skills and knowledge to allow them to participate effectively in the creation and growth of high-impact pharmaceutical business ventures. Its graduates will be ideally positioned to initiate their own start-up companies or join existing biotech or pharmaceutical businesses.
Students will learn how to develop and assess a new business concept, and how to raise finance for and market a business and its outputs. They will build their scientific skill set by exploring four scientific research areas in pharmaceutics, and will interact closely with and be mentored by those who have direct experience of initiating a start-up business.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits), a scientific research project (30 credits) and a business case development project (30 credits).
Students select three optional modules in term one (from a choice of four), and a further optional module (from a choice of five) in term two.
Students undertake two projects which culminate in two written reports and oral presentations. One is a short laboratory research project, while the second involves the development of a business case for a new pharmaceutical endeavour.
Teaching and learning
The programme is delivered through a combination of lectures, tutorials, seminars and practical sessions, as well as industrial visits. Assessment is through a combination of written examinations, coursework assignments and project work.
Further information on modules and degree structure is available on the department website: Pharmaceutical Formulation and Entrepreneurship MSc
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
Graduates from this MSc find work in various areas of the pharmaceutical and biotechnology industries. They are fully equipped with the skills to start their own businesses, and can approach UCL Innovation and Enterprise to assist with this if desired. Alternatively, they may join small biotech or major pharmaceutical companies, pursue further research in academia, work in consulting, or join world-leading technology companies where there is increasing emphasis on healthcare and the life sciences. For instance, recent graduates have undertaken PhD research at the University of Cambridge or found work with start-ups such as Intract Pharma.
Employability skills are embedded in the programme, with emphasis placed on the development of "soft" skills and a series of workshop sessions organised on CV writing, undertaking interviews, and networking. We make extensive efforts to provide opportunities for students to meet with potential employers. Students from this MSc are highly competitive in the global jobs market.
This programme is unique in equipping students with a broad skill set in both medicines design and entrepreneurship. It is delivered by world-leading academics in both the UCL School of Pharmacy and UCL School of Management.
UCL staff with direct experience of launching a pharmaceutical start-up will teach students best practice and how to overcome the major challenges involved in enterprises of this kind.
UCL’s central London location combines state-of-the-art research with an entrepreneurial dynamic that fosters start-up creation, and provides access to venture capitalists, business angels, and world-leading pharmaceutical companies. UCL Innovation and Enterprise, UCL’s centre for entrepreneurship and business interaction, offers UCL students direct practical support in launching a business.
The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental and Translational Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas.
The Programme draws on the world-class research and teaching in experimental therapeutics at Oxford University and offers a unique opportunity to gain an understanding of the principles that underpin clinical research and to translate this into good clinical and research practice.
Visit the website https://www.conted.ox.ac.uk/about/msc-in-experimental-therapeutics
If your application is completed by this January deadline and you fulfil the eligibility criteria, you will be automatically considered for a graduate scholarship. For details see: http://www.ox.ac.uk/admissions/graduate/fees-and-funding/graduate-scholarships.
The MSc in Experimental and Translational Therapeutics is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years. Students are full members of the University of Oxford and are matriculated as members of an Oxford college.
The modules in this programme can also be taken as individual short courses. It is possible to transfer credit from up to three previously completed modules into the MSc programme, if the time elapsed between commencement of the accredited module(s) and registration for the MSc is not more than two years.
- The Structure of Clinical Trials and Experimental Therapeutics
- Drug Development, Pharmacokinetics and Imaging
- Pharmacodynamics, Biomarkers and Personalised Therapy
- Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance
- How to do Research on Therapeutic Interventions: Protocol Preparation
- Biological Therapeutics
The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.
By the end of the MSc programme, students should understand the following core principles:
- Development, marketing and regulations of drugs
- Pharmaceutical factors that affect drug therapy
- Pharmacokinetics, pharmacogenetics and pharmacodynamics
- Adverse drug reactions, drug interactions, and pharmacovigilance
- Designing phase I, II and III clinical trials for a range of novel therapeutic interventions (and imaging agents).
- Application of statistics to medicine
- Laboratory assays used to support trial end-points
- Use of non-invasive imaging in drug development
- Application of analytical techniques
By the end of the programme, students should be equipped to:
- demonstrate a knowledge of the principles, methods and techniques for solving clinical research problems and translate this into good clinical and research practice
- apply skills gained in techniques and practical experience from across the medical and biological sciences
- develop skills in managing research-based work in experimental therapeutics
- carry out an extended research project involving a literature review, problem specification and analysis in experimental therapeutics and write a short dissertation
Guidance from the UK Royal College of Physician's Faculty of Pharmaceutical Medicine
The Faculty have confirmed that if enrolled for Pharmaceutical Medicine Specialty Training (PMST), trainees may be able to use knowledge provided by Experimental Therapeutics modules to cover aspects of a module of the PMST curriculum. Trainees are advised to discuss this with their Educational Supervisor.
Experimental Therapeutics modules may also be used to provide those pursuing the Faculty's Diploma in Pharmaceutical Medicine (DPM) with the necessary knowledge required to cover the Diploma syllabus. Applicants for the DPM exam are advised to read the DPM syllabus and rules and regulations.
Members of the Faculty of Pharmaceutical Medicine who are registered in the Faculty's CPD scheme can count participation in Experimental Therapeutics modules towards their CPD record. Non-members may wish to obtain further advice about CPD credit from their Royal College or Faculty.
To complete the MSc, students need to:
Attend the six modules and complete an assessed written assignment for each module.
Complete a dissertation on a topic chosen in consultation with a supervisor and the Course Director.
The dissertation is founded on a research project that builds on material studied in the taught modules. The dissertation should normally not exceed 15,000 words.
The project will normally be supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.
The following are topics of dissertations completed by previous students on the course:
- The outcomes of non-surgical management of tubal pregnancy; a 6 month study of the South East London population
- Analysis of the predictive and prognostic factors of outcome in a cohort of patients prospectively treated with perioperative chemotherapy for adenocarcinoma of the stomach or of the gastroesophageal junction
- Evolution of mineral and bone disorder in early Chronic Kidney Disease (CKD): the role of FGF23 and vitamin D
- Survey of patients' knowledge and perception of the adverse drug reporting scheme (yellow cards) in primary care
- The predictive role of ERCC1 status in oxaliplatin based Neoadjuvant for metastatic colorectal cancer (CRC) to the liver
- Endothelial Pathophysiology in Dengue - Dextran studies during acute infection
- Literature review of the use of thalidomide in cancer
- An investigation into the phenotypical and functional characteristics of mesenchymal stem cells for clinical application
- Identification of genetic variants that cause capecitabine and bevacizumab toxicity
- Bridging the evidence gap in geriatric medicines via modelling and simulations
The class-based modules will include a period of preparatory study, a week of intensive face-to-face lectures and tutorials, followed by a period for assignment work. Attendance at modules will be a requirement for study. Some non-classroom activities will be provided at laboratory facilities elsewhere in the University. The course will include taught material on research skills. A virtual learning environment (VLE) will provide between-module support.
The taught modules will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers. Practical work aims to develop the students' knowledge and understanding of the subject.
Find out how to apply here - http://www.ox.ac.uk/admissions/graduate/applying-to-oxford
Biomedical sciences underwent a spectacular evolution during the past decades. New diseases such as bird flu arose, whereas others such as AIDS and diabetes have expanded. At the same time, researchers are discovering new ways to fight these diseases. The human genome has been decoded, gene technology is steadily growing, immunotherapy has been introduced for the treatment of several cancers and the first steps in the direction of stem cell therapy have been made. The laboratories at KU Leuven and University Hospital Gasthuisberg deliver cutting edge work in the field of disease and development of new therapies, stretching from bench to bedside. The Master of Biomedical Sciences at KU Leuven allows students to live this journey themselves, hands on.
Do you dream of working on the frontline of the ongoing battle for a better understanding of human health and diseases? Are dedicated to applying this knowledge to better prevention and treatment options? Then this programme is for you. During the two master's years you will be truly immersed in scientific biomedical research. By doing scientific research in a domestic or foreign laboratory, you will gain thorough know-how, strengthen your scientific skills and learn the newest scientific methods. All of these skills and accumulated knowledge will be applied in the most important part of the master's programme: your master's thesis.
The main goal of the curriculum is to train researchers in biomedical sciences by providing a rigorous scientific training based on the acquisition of knowledge, the collection and interpretation of information and the use of modern research techniques. This is expected to stimulate the critical thinking and independence required to address a specific research question related to (dys)function of the human body and its interaction with the environment. Furthermore, the curriculum provides broad, intellectually rigorous training allowing for a wide array of job opportunities in industry, research centres and society.
The aims of the curriculum follow the educational principles of KU Leuven, important among which is the independence of the student. For the acquisition of knowledge, the university uses its own high-quality interdisciplinary scientific research. KU Leuven aims to be a centre of critical thinking where, in addition to factual knowledge, people are stimulated to identify, define and solve problems.
The quality of the curriculum is guaranteed due to the strong interconnection between education and research in the Biomedical Sciences in the broadest sense. The faculty commits itself to a future-oriented educational project in an academic setting that is at once intellectually stimulating, socially supportive and student friendly.
Internationalisation has become an integral part of the profile of researchers in biomedical sciences. International exchange is the key to opening mindsets to global solutions in health and disease. Graduates can expect to embark on international-level careers in very diverse areas touching on human health.
First and foremost, biomedical scientists are prepared for a personal career full of exciting scientific research in academic or pharmaceutical laboratories dedicated to improving knowledge in human health and finding prevention strategies and cures for diseases. Beyond this, there are many different directions open to you.
Many graduates go on to careers in consultancy, policy, sales and marketing, communication and management in areas related to human health, such as the pharmaceutical industry, scientific writing agencies, regulatory agencies and government administration. Graduates find rewarding work in a wide variety of sectors: the pharmaceutical industry, the academic or educational world, healthcare, the environmental sector and food inspection, among others.
Programme graduates are in high demand in the pharmaceutical and medical industry. As a biomedical scientist, for example, you provide thoroughly prepared research, which is a crucial phase in the development of new drugs and other medical products. It is also possible to cooperate with the set-up and follow-up of preclinical trials in the pharmaceutical industry. The programme gives you the perfect profile for clinical trial design, as well as the monitoring and conducting of these trials, on both the business and clinical sides of the process.
You can also work for service companies that deliver or develop products or equipment to the medical sector. Positions in government are also open to you, especially in the area of public health. Some biomedical scientists choose to specialise in the legislation around patents and the protection of biomedical discoveries, and others begin careers as biology, chemistry or biotechnology teachers. Additionally, there is a current need for experts who can clearly communicate scientific information and research results to non-specialists and the general public.
The Clinical Pharmacology course will give you the advanced skills and knowledge to evaluate the safety of new medicinal products in preparation for medical approval. It is one of three modular programmes in Pharmaceutical Medicine designed for working physicians, clinical scientists and allied health professionals interested in the clinical development process.
Clinical Pharmacology is the study of how drugs influence human physiology and the way the body responds. This study forms a vital part of the clinical development of new medicines and requires an advanced understanding of pre-clinical science, as well as the ethical and legal requirements for specialist research programmes. A well-designed clinical pharmacology programme informs the final regulatory of a new medicine. Therefore, generating skilled clinical pharmacologists is critical for the efficiency of future drug development.
This course will provide you with a broad knowledge and understanding of the drug development process and the medical aspects of the marketing of pharmaceutical products. You will also have opportunities to undertake advanced research projects and the possibility of one or more thesis publications.
The study programme is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, including 60 credits from a dissertation of around 15,000 - 18,000 words. The Postgraduate Diploma pathway will require modules totalling 120 credits, while the Postgraduate Certificate will require you to study modules totalling of 60 credits to complete the course.
If you are studying full-time, you will complete the course in one year, from September to September. If you are studying for the MSc qualification part-time, your programme will take up to four years to complete. The Postgraduate Diploma and Certificate pathways are both part-time courses. The Postgraduate Diploma will take two to three years to complete and the Postgraduate Certificate up to two years.
This course is for those working in or seeking to work in the field of clinical drug development. It covers all aspects of the clinical development process through from the earliest studies to post marketing activities. It will enhance knowledge and skills in all aspects of clinical research, drug regulation and drug safety.
The primary method of assessment for this course is a combination of coursework and written examinations. The MSc study programme also requires a research and dissertation on the subject of clinical pharmacology.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.